1
|
Wee LE, Sundarajoo M, Quah WF, Farhati A, Huang JY, Chua YY. Health-related quality of life and its association with outcomes of outpatient parenteral antibiotic therapy. Eur J Clin Microbiol Infect Dis 2019; 39:765-772. [PMID: 31873862 DOI: 10.1007/s10096-019-03787-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2019] [Accepted: 12/02/2019] [Indexed: 01/09/2023]
Abstract
While health-related quality of life (HRQoL) is an important component of patient-centred care, few studies have looked at the association between HRQoL and outcomes while on OPAT. From 2014 to 2017, we conducted a prospective cohort study of all patients referred to Singapore General Hospital's (SGH) OPAT service. At baseline, we collected sociodemographic, clinical, and treatment-related factors for OPAT recipients. We also measured baseline HRQoL using the EuroQoL EQ5D-3 L. We evaluated the association between HRQoL and the following outcomes: complications experienced while on OPAT, early termination requiring readmission during planned course of OPAT, all-cause readmission 30 days after completion of OPAT, and return to work while on OPAT. We used chi-squared test for univariate analysis and cox regression for multivariate analysis. From 2014 to 2017, 1213 patients received OPAT at our centre. Of those, 13.2% (160/1213) developed complications. About 10% (132/1213) of patients were readmitted while on OPAT and OPAT was terminated early. Amongst patients who completed OPAT (N = 1081), about 3.6% (39/1081) were readmitted within 30 days after OPAT completion. About half (50.8%, 278/547) returned to work while on OPAT. On multivariate analysis, patients with perfect health-related quality of life (HRQoL) (adjusted relative risk, aRR = 0.62, 95%CI = 0.45-0.85) were less likely to experience complications, had lower risk of OPAT termination (aRR = 0.57, 95%0.38-0.86), and were more likely to return to work while on OPAT (aRR = 1.94, 95%CI = 1.30-2.89). HRQoL at baseline was significantly associated with lower risk of complications and early OPAT termination, as well as greater likelihood of return to work while on OPAT.
Collapse
Affiliation(s)
- Liang En Wee
- Duke-NUS Graduate Medical School, Singapore, Singapore. .,Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.
| | | | - Way-Fang Quah
- Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore
| | - Ahmad Farhati
- Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore
| | - Jie-Ying Huang
- Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore
| | - Ying-Ying Chua
- Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore
| |
Collapse
|
2
|
McNamara JF, Righi E, Wright H, Hartel GF, Harris PNA, Paterson DL. Long-term morbidity and mortality following bloodstream infection: A systematic literature review. J Infect 2018; 77:1-8. [PMID: 29746948 DOI: 10.1016/j.jinf.2018.03.005] [Citation(s) in RCA: 50] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2018] [Accepted: 03/17/2018] [Indexed: 10/17/2022]
Abstract
OBJECTIVES Bloodstream infection results in significant short-term morbidity and mortality. No literature review has studied the long-term outcome following a bloodstream infection. This PROSPERO registered systematic review evaluated studies, which measured the association of a bloodstream infection with long-term morbidity and mortality. METHODS Databases were systematically searched for studies of adult patients reporting morbidity and/or mortality one year or more following a bloodstream infection in comparison to a matched cohort without a bloodstream infection. RESULTS Ten observational studies were included in the final analysis. Five studies assessed only mortality, two assessed morbidity and mortality and three studies assessed morbidity only. The one year mortality ranged from between 8 and 48% for patients with bloodstream infection. The pooled risk ratio of death at one year was significantly higher for patients with bloodstream infection when compared to the matched cohort (RR 4.04 [95% CI 1.84-8.87]). CONCLUSIONS Bloodstream infection was associated with poor long-term outcome measured at one year when compared to matched controls. More evidence is needed to determine if this association is causative.
Collapse
Affiliation(s)
- John F McNamara
- Centre for Clinical Research, Royal Brisbane and Women's Hospital, University of Queensland, Building 71/918, Brisbane QLD 4029, Australia; The Prince Charles Hospital, Chermside, Brisbane, Australia.
| | - Elda Righi
- Centre for Clinical Research, Royal Brisbane and Women's Hospital, University of Queensland, Building 71/918, Brisbane QLD 4029, Australia; Infectious Diseases Division, Santa Maria della Misericordia University Hospital, Udine, Italy
| | - Hugh Wright
- Centre for Clinical Research, Royal Brisbane and Women's Hospital, University of Queensland, Building 71/918, Brisbane QLD 4029, Australia
| | - Gunter F Hartel
- Statistics Group, Berghofer Centre, Queensland Institute of Medical Research, Brisbane, Australia
| | - Patrick N A Harris
- Centre for Clinical Research, Royal Brisbane and Women's Hospital, University of Queensland, Building 71/918, Brisbane QLD 4029, Australia
| | - David L Paterson
- Centre for Clinical Research, Royal Brisbane and Women's Hospital, University of Queensland, Building 71/918, Brisbane QLD 4029, Australia
| |
Collapse
|
3
|
Return to the workforce following infective endocarditis-A nationwide cohort study. Am Heart J 2018; 195:130-138. [PMID: 29224640 DOI: 10.1016/j.ahj.2017.09.009] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/11/2017] [Accepted: 09/08/2017] [Indexed: 01/22/2023]
Abstract
BACKGROUND The ability to return to work after infective endocarditis (IE) holds important socioeconomic consequences for both patients and society, yet data on this issue are sparse. We examined return to the workforce and associated factors in IE patients of working age. METHODS Using Danish nationwide registries, we identified 1,065 patients aged 18-60 years with a first-time diagnosis of IE (1996-2013) who were part of the workforce prior to admission and alive at discharge. RESULTS One year after discharge, 765 (71.8%) patients had returned to the workforce, 130 (12.2%) were on paid sick leave, 76 (7.1%) received disability pension, 23 (2.2%) were on early retirement, 65 (6.1%) had died, and 6 (0.6%) had emigrated. Factors associated with return to the workforce were identified using multivariable logistic regression. Younger age (18-40 vs 56-60 years; odds ratio, 2.85; 95% CI, 1.71-4.76) and higher level of education (higher educational level vs basic school; 5.47, 2.05-14.6) and income (highest quartile vs lowest; 3.17, 1.85-5.46) were associated with return to the workforce. Longer length of hospital stay (>90 vs 14-30 days; 0.16, 0.07-0.38); stroke during IE admission (0.38, 0.21-0.71); and a history of chronic kidney disease (0.29, 0.11-0.75), chronic obstructive pulmonary disease (0.31, 0.13-0.71), and malignancy (0.39, 0.22-0.69) were associated with a lower likelihood of returning to the workforce. CONCLUSIONS Seven of 10 patients who were part of the workforce prior to IE and alive at discharge were part of the workforce 1 year later. Younger age, higher socioeconomic status, and absence of major comorbidities were associated with return to the workforce.
Collapse
|
4
|
Numé AK, Kragholm K, Carlson N, Kristensen SL, Bøggild H, Hlatky MA, Torp-Pedersen C, Gislason G, Ruwald MH. Syncope and Its Impact on Occupational Accidents and Employment. Circ Cardiovasc Qual Outcomes 2017; 10:CIRCOUTCOMES.116.003202. [DOI: 10.1161/circoutcomes.116.003202] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/03/2016] [Accepted: 03/07/2017] [Indexed: 11/16/2022]
Abstract
Background—
First-time syncopal episodes usually occur in adults of working age, but their impact on occupational safety and employment remains unknown. We examined the associations of syncope with occupational accidents and termination of employment.
Methods and Results—
Through linkage of Danish population-based registers, we included all residents 18 to 64 years from 2008 to 2012. Among 3 410 148 eligible individuals, 21 729 with a first-time diagnosis of syncope were identified, with a median age 48.4 years (first to third quartiles, 33.0–59.5), and 10 757 (49.5%) employed at time of the syncope event. Over a median follow-up of 3.2 years (first to third quartiles, 2.0–4.5), 622 people with syncope had an occupational accident requiring hospitalization (2.1/100 person-years). In multiple Poisson regression analysis, the incidence rate ratio in the employed syncope population was higher than in the employed general population (1.44; 95% confidence interval [CI], 1.33–1.55) and more pronounced in people with recurrences (2.02; 95% CI, 1.47–2.78). The 2-year risk of termination of employment was 31.3% (95% CI, 30.4%–32.3%), which was twice the risk of the reference population (15.2%; 95% CI, 14.7%–15.7%), using the Aalen–Johansen estimator. Factors associated with termination of employment were age <40 years (incidence rate ratio, 1.48; 95% CI, 1.37–1.59), cardiovascular disease (1.20; 95% CI, 1.06–1.36), depression (1.72; 95% CI, 1.55–1.90), and low educational level (2.61; 95% CI, 2.34–2.91).
Conclusions—
In this nationwide cohort, syncope was associated with a 1.4-fold higher risk of occupational accidents and a 2-fold higher risk of termination of employment compared with the employed general population.
Collapse
Affiliation(s)
- Anna-Karin Numé
- From the Department of Cardiology (A.N., N.C., S.L.K., G.G., M.H.R.) and Department of Nephrology (N.C.), Copenhagen University Herlev Gentofte Hospital, Hellerup, Denmark; the Departments of Cardiology and Clinical Epidemiology, Aalborg University Hospital, Denmark (K.K., H.B., C.T.-P.); the Department of Health Research and Policy (M.A.H.) and Department of Medicine (M.A.H.), Stanford University School of Medicine, CA; The National Institute of Public Health, University of Southern Denmark,
| | - Kristian Kragholm
- From the Department of Cardiology (A.N., N.C., S.L.K., G.G., M.H.R.) and Department of Nephrology (N.C.), Copenhagen University Herlev Gentofte Hospital, Hellerup, Denmark; the Departments of Cardiology and Clinical Epidemiology, Aalborg University Hospital, Denmark (K.K., H.B., C.T.-P.); the Department of Health Research and Policy (M.A.H.) and Department of Medicine (M.A.H.), Stanford University School of Medicine, CA; The National Institute of Public Health, University of Southern Denmark,
| | - Nicolas Carlson
- From the Department of Cardiology (A.N., N.C., S.L.K., G.G., M.H.R.) and Department of Nephrology (N.C.), Copenhagen University Herlev Gentofte Hospital, Hellerup, Denmark; the Departments of Cardiology and Clinical Epidemiology, Aalborg University Hospital, Denmark (K.K., H.B., C.T.-P.); the Department of Health Research and Policy (M.A.H.) and Department of Medicine (M.A.H.), Stanford University School of Medicine, CA; The National Institute of Public Health, University of Southern Denmark,
| | - Søren L. Kristensen
- From the Department of Cardiology (A.N., N.C., S.L.K., G.G., M.H.R.) and Department of Nephrology (N.C.), Copenhagen University Herlev Gentofte Hospital, Hellerup, Denmark; the Departments of Cardiology and Clinical Epidemiology, Aalborg University Hospital, Denmark (K.K., H.B., C.T.-P.); the Department of Health Research and Policy (M.A.H.) and Department of Medicine (M.A.H.), Stanford University School of Medicine, CA; The National Institute of Public Health, University of Southern Denmark,
| | - Henrik Bøggild
- From the Department of Cardiology (A.N., N.C., S.L.K., G.G., M.H.R.) and Department of Nephrology (N.C.), Copenhagen University Herlev Gentofte Hospital, Hellerup, Denmark; the Departments of Cardiology and Clinical Epidemiology, Aalborg University Hospital, Denmark (K.K., H.B., C.T.-P.); the Department of Health Research and Policy (M.A.H.) and Department of Medicine (M.A.H.), Stanford University School of Medicine, CA; The National Institute of Public Health, University of Southern Denmark,
| | - Mark A. Hlatky
- From the Department of Cardiology (A.N., N.C., S.L.K., G.G., M.H.R.) and Department of Nephrology (N.C.), Copenhagen University Herlev Gentofte Hospital, Hellerup, Denmark; the Departments of Cardiology and Clinical Epidemiology, Aalborg University Hospital, Denmark (K.K., H.B., C.T.-P.); the Department of Health Research and Policy (M.A.H.) and Department of Medicine (M.A.H.), Stanford University School of Medicine, CA; The National Institute of Public Health, University of Southern Denmark,
| | - Christian Torp-Pedersen
- From the Department of Cardiology (A.N., N.C., S.L.K., G.G., M.H.R.) and Department of Nephrology (N.C.), Copenhagen University Herlev Gentofte Hospital, Hellerup, Denmark; the Departments of Cardiology and Clinical Epidemiology, Aalborg University Hospital, Denmark (K.K., H.B., C.T.-P.); the Department of Health Research and Policy (M.A.H.) and Department of Medicine (M.A.H.), Stanford University School of Medicine, CA; The National Institute of Public Health, University of Southern Denmark,
| | - Gunnar Gislason
- From the Department of Cardiology (A.N., N.C., S.L.K., G.G., M.H.R.) and Department of Nephrology (N.C.), Copenhagen University Herlev Gentofte Hospital, Hellerup, Denmark; the Departments of Cardiology and Clinical Epidemiology, Aalborg University Hospital, Denmark (K.K., H.B., C.T.-P.); the Department of Health Research and Policy (M.A.H.) and Department of Medicine (M.A.H.), Stanford University School of Medicine, CA; The National Institute of Public Health, University of Southern Denmark,
| | - Martin H. Ruwald
- From the Department of Cardiology (A.N., N.C., S.L.K., G.G., M.H.R.) and Department of Nephrology (N.C.), Copenhagen University Herlev Gentofte Hospital, Hellerup, Denmark; the Departments of Cardiology and Clinical Epidemiology, Aalborg University Hospital, Denmark (K.K., H.B., C.T.-P.); the Department of Health Research and Policy (M.A.H.) and Department of Medicine (M.A.H.), Stanford University School of Medicine, CA; The National Institute of Public Health, University of Southern Denmark,
| |
Collapse
|
5
|
Kehrer M, Hallas J, Bælum J, Jensen TG, Pedersen C, Lassen AT. Reduced ability to work both before and after infectious spondylodiscitis in working-age patients. Infect Dis (Lond) 2016; 49:95-103. [PMID: 27636869 DOI: 10.1080/23744235.2016.1217348] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
Abstract
BACKGROUND As little is known about the ability to work in patients with infectious spondylodiscitis, we compared the relation between the workforce before infection with that of a reference population and described the patients' ability to work after infection including predictors of return to work (RTW). METHODS We identified all patients aged 20-57 years treated for infectious spondylodiscitis January 1994-May 2009 at hospitals in Funen County, Denmark. The work status of each week from 2 years before until 2 years after index date was compared with that of a reference population. Time to RTW was described using cumulative incidence curves and univariate cause-specific Cox-regression analyses (hazard ratios - HRs). RESULTS Of 112 identified patients, 8 (7%) died within the first year and 48 (43%) were part of the workforce 1 year before index. Through the entire observation period, the patients had lower affiliation to the workforce compared with the reference population. During the observation period, the proportion of patients on permanent disability pension increased from 24% to 38% and the proportion of self-supporters decreased from 58% to 33%. Seventy-three per cent of the patients being part of the workforce 1 year before index returned to the workforce within the 2 year follow-up. Main predictor of RTW was being part of the workforce 1 year before index (HR = 7.8; CI: 2.4-25.3). CONCLUSIONS Patients with infectious spondylodiscitis were less likely to be part of the workforce before infection compared with a reference population and infection further lowered their ability to RTW.
Collapse
Affiliation(s)
- Michala Kehrer
- a Department of Clinical Research , University of Southern Denmark , Odense , Denmark.,b Department of Infectious Diseases, Odense University Hospital , Odense , Denmark
| | - Jesper Hallas
- c Department of Clinical Biochemistry and Pharmacology , Odense University Hospital , Odense , Denmark
| | - Jesper Bælum
- d Occupational and Environmental Medicine , University of Southern Denmark , Odense , Denmark
| | - Thøger Gorm Jensen
- e Department of Clinical Microbiology , Odense University Hospital , Odense , Denmark
| | - Court Pedersen
- b Department of Infectious Diseases, Odense University Hospital , Odense , Denmark
| | - Annmarie Touborg Lassen
- a Department of Clinical Research , University of Southern Denmark , Odense , Denmark.,f Department of Emergency Medicine , Odense University Hospital , Odense , Denmark
| |
Collapse
|
7
|
Søgaard M, Thomsen RW, Bang RB, Schønheyder HC, Nørgaard M. Trends in length of stay, mortality and readmission among patients with community-acquired bacteraemia. Clin Microbiol Infect 2015; 21:789.e1-7. [PMID: 26003278 DOI: 10.1016/j.cmi.2015.05.018] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2014] [Revised: 04/30/2015] [Accepted: 05/08/2015] [Indexed: 11/28/2022]
Abstract
In patients hospitalized with severe infection, premature discharge may lead to increased risk of readmission and death. We conducted this population-based cohort study to examine trends in length of stay (LOS) and 30-day mortality and hospital readmission rates after bacteraemia from 1994 through 2013. We used Cox regression to compute hazard ratios (HRs) for 30-day mortality and 30-day postdischarge readmission rates by calendar period and quintiles of LOS, adjusting for age, sex and comorbidity. Among 7618 patients hospitalized with community-acquired bacteraemia during the study period, median LOS decreased from 12 days (quartiles 7-21 days) in 1994-1998 to 9 days (quartiles 6-16 days) in 2009-2013 (25% relative reduction). The 30-day mortality fell from 16.7% to 15.0%, yielding an adjusted 30-day HR of 0.80 (95% confidence interval (CI) 0.68-0.95). Almost one fifth (19.4%) of patients discharged alive were readmitted within 30 days. Concurrently, the adjusted HR of readmission tended to increase (adjusted HR 1.09, 95% CI 0.93-1.28) in 2009-2013 compared with 1994-1998. Compared with the middle quintile of LOS (9-12 days), the risk of readmission was slightly higher for patients discharged within 5 days (adjusted HR 1.12, 95% CI 0.92-1.37), especially for readmission due to infection (adjusted HR 1.38, 95% CI 1.03-1.85). Readmission risk was lowest for 6 to 8 days LOS (adjusted HR 0.80, 95% CI 0.67-0.95) and highest for LOS ≥23 days (adjusted HR 1.30, 95% CI 1.11-1.53). The declining LOS after community-acquired bacteraemia between 1994 and 2013 was not accompanied by increased 30-day mortality but by slightly increased readmission rates.
Collapse
Affiliation(s)
- M Søgaard
- Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.
| | - R W Thomsen
- Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark
| | - R B Bang
- Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark
| | - H C Schønheyder
- Department of Clinical Microbiology, Aalborg Hospital, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
| | - M Nørgaard
- Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark
| |
Collapse
|